Aera Therapeutics
Aera Therapeutics
aeratx.com

Locations

Boston, MA, USA

industry

Biotechnology · Data and Analytics · DeepTech · Design · Health

Size

51-200 employees

Stage

Series B

founded in

2021

Aera Therapeutics is a biotechnology company that uses its proprietary protein nanoparticle (PNP) delivery platform to help genetic medicines reach their full potential. Aera's platform, which is based on endogenous human proteins, is being developed to address the limitations of current delivery technologies and to extend the reach of genetic medicines to different tissues and applications, thereby benefiting more patients across a broader range of disease areas. In addition, Aera's licensed technology includes a therapeutic enzyme platform based on the discovery of novel, compact, and programmable gene-editing enzymes.

Something looks off?
Open jobs at Aera Therapeutics

On-site & Remote